Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
Kataoka H, Shimada Y, Kimura T, Nishio S, Nakatani S, Mochizuki T, Tsuchiya K, Hoshino J, Hattanda F, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Hayashi H, Makabe S, Manabe S, Mitobe M, Sekine A, Suwabe T, Kai H, Kurashige M, Seta K, Shimazu K, Moriyama T, Sato M, Otsuka T, Katayama K, Shimabukuro W, Fujimaru T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I, Muto S.
Clin Exp Nephrol. 2023 Oct;27(10):809-818. PMID: 37368094
Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of Japan.
Tomonori Kimura, Hidekazu Ikeuchi, Mitsuaki Yoshino, Ryuichi Sakate, Shoichi Maruyama, Ichiei Narita, Keiju Hiromura.
Clin Exp Nephrol., 2023 Jun;27(6):519-527. PMID: 36929044
Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records.
Naoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, Yoshitaka Isaka, Ichiei Narita.
Clin Exp Nephrol., 2023 Jul 29. PMID: 37515698
Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records.
Naoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, Takehiko Wada, Kengo Furuichi, Hirokazu Okada, Yoshitaka Isaka, Ichiei Narita.
Sci Rep., 2023 Sep 7;13(1):14771. PMID: 37679492